Forma Therapeutics Holdings, Inc. Reports Unaudited Financial Results for the First Quarter Ended March 31, 2021
Forma Therapeutics Holdings, Inc. reported unaudited financial results for the first quarter ended March 31, 2021. Loss from operations was $36,210,000 against $32,226,000 a year ago. Net loss was $35,960,000 against profit of $11,230,000 a year ago. Net loss per basic share was $0.76 against profit of $2.29 a year ago. Net loss per diluted share was $0.76 against profit of $0.36 a year ago.